Cargando…
Long-Term Immune Recovery After Hematopoietic Stem Cell Transplantation for ADA Deficiency: a Single-Center Experience
Unconditioned hematopoietic stem cell transplantation (HSCT) is the recommended treatment for patients with adenosine deaminase (ADA)-deficient severe combined immunodeficiency with an HLA-matched sibling donor (MSD) or family donor (MFD). Improved overall survival (OS) has been reported compared to...
Autores principales: | Kreins, Alexandra Y., Velasco, Helena F., Cheong, Kai-Ning, Rao, Kanchan, Veys, Paul, Worth, Austen, Gaspar, H. Bobby, Booth, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821083/ https://www.ncbi.nlm.nih.gov/pubmed/34654999 http://dx.doi.org/10.1007/s10875-021-01145-w |
Ejemplares similares
-
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
por: Booth, Claire, et al.
Publicado: (2009) -
Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome
por: Laberko, Alexandra, et al.
Publicado: (2021) -
ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation
por: Barzaghi, Federica, et al.
Publicado: (2019) -
Different Phenotypic Presentations of X-Linked Lymphoproliferative Disease in Siblings with Identical Mutations
por: Nademi, Zohreh, et al.
Publicado: (2019) -
Novel pathogenic ADA2 mutations: alert to diagnosis challenge of ADA2 deficiency
por: Wu, Zhijie, et al.
Publicado: (2023)